Correlation Engine 2.0
Clear Search sequence regions
Bookmark Forward

QuickView for glycopyrrolate (compound)


PubChem
Name: Glycopyrrolate
PubChem Compound ID: 11693
Description: A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.
Molecular formula: C19H28BrNO3
Molecular weight: 398.335 g/mol
Synonyms:
596-51-0; AHR 504; Pyrrolidinium, 1,1-dimethyl-3-hydroxy-, bromide, alpha-cyclopentylmandelate; Glycopyrrolate bromide; Gastrodyn; Glycopyrronii bromidum; Ritropirronium bromide [INN]; 3-Hydroxy-1,1-dimethylpyrrolidinium bromide alpha-cyclopentylmandelate; Bromure de glycopyrronium [INN-French]; 53808-86-9.
show more »
DrugBank
Identification
Name: Glycopyrrolate
Name (isomeric): DB00986
Drug Type: small molecule
Description: A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.
Synonyms:
Glycopyrronium bromide
Brand: Robinul, Robinal, Asecryl, Robanul, Tarodyl, Tarodyn, Nodapton, Gastrodyn
Category: Muscarinic Antagonists, Adjuvants, Anesthesia, Anti-cholinergic Agents
CAS number: 596-51-0
Pharmacology
Indication: For use as a preoperative antimuscarinic to reduce salivary, tracheobronchial, and pharyngeal secretions, to reduce the volume and free acidity of gastric secretions and to block cardiac vagal inhibitory reflexes during induction of anesthesia and intubation.
Pharmacology:
Glycopyrrolate decreases acid secretion in the stomach. Hence it can be used for treating ulcers in the stomach and small intestine, in combination with other medications. In anesthesia, glycopyrrolate injection serves as a preoperative antimuscarinic operation that reduces salivary, tracheobronchial, and pharyngeal secretions, as well as decreases...
show more »
Mechanism of Action:
Glycopyrrolate binds competitively to the muscarinic acetylcholine receptor. Like other anticholinergic (antimuscarinic) agents, it inhibits the action of acetylcholine on structures innervated by postganglionic cholinergic nerves and on smooth muscles that respond to acetylcholine but lack cholinergic innervation. These peripheral cholinergic rece...
show more »
Absorption: Rapidly absorbed (1-2 minutes) after intravenous injection
Half Life: 0.6-1.2 hours
Toxicity: Side effects include dry mouth, difficult urinating, heachaches, diarrhea and constipation. The medication also induces drowsiness or blurred vision. LD50=709 mg/kg (rat, oral).
Affected organisms: Humans and other mammals
Interactions
Food interaction:
Take without regard to meals.
Drug interaction:
TriprolidineTriprolidine and Glycopyrrolate, two anticholinergics, may cause additive anticholinergic effects and enhance their adverse/toxic effects. Monitor for enhanced anticholinergic effects.
DonepezilPossible antagonism of action
TrospiumTrospium and Glycopyrrolate, two anticholinergics, may cause additive anticholinergic effects and enhanced adverse/toxic effects. Monitor for enhanced anticholinergic effects.
TacrineThe therapeutic effects of the central acetylcholinesterase inhibitor, Tacrine, and/or the anticholinergic, Glycopyrrolate, may be reduced due to antagonism. The interaction may be beneficial when the anticholinergic action is a side effect. Monitor for decreased efficacy of both agents.
RivastigminePossible antagonism of action
show more »

Targets